Phase 1/2 Study of Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Latest Information Update: 26 Jul 2024
At a glance
- Drugs Locnartecan (Primary) ; Temozolomide (Primary) ; Vincristine (Primary)
- Indications Alveolar soft part sarcoma; Ewing's sarcoma; Rhabdomyosarcoma; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 25 Jul 2024 Planned initiation date changed to 30 Jul 2024.
- 03 Jul 2024 Planned initiation date changed from 26 Jun 2024 to 9 Jul 2024.
- 20 Jun 2024 Planned initiation date changed to 26 Jun 2024.